-
1
-
-
34547792390
-
Chronic enteropathies in dogs: evaluation of risk factors for negative outcome
-
Allenspach K., Wieland B., Gröne A., Gaschen F. Chronic enteropathies in dogs: evaluation of risk factors for negative outcome. J. Vet. Intern. Med. 2007, 21:700-708.
-
(2007)
J. Vet. Intern. Med.
, vol.21
, pp. 700-708
-
-
Allenspach, K.1
Wieland, B.2
Gröne, A.3
Gaschen, F.4
-
2
-
-
0037133280
-
Advanced glycation end products activate endothelium through signaling signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses
-
Basta G., Lazzerini G., Massaro M., Simoncini T., Tanganelli P., Fu C., Kislinger T., Stern D.M., Schmidt A.M., De Caterina R. Advanced glycation end products activate endothelium through signaling signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses. Circulation 2002, 105:816-822.
-
(2002)
Circulation
, vol.105
, pp. 816-822
-
-
Basta, G.1
Lazzerini, G.2
Massaro, M.3
Simoncini, T.4
Tanganelli, P.5
Fu, C.6
Kislinger, T.7
Stern, D.M.8
Schmidt, A.M.9
De Caterina, R.10
-
3
-
-
27744453362
-
Understanding RAGE, the receptor for advanced glycation end products
-
Bierhaus A., Humpert P.M., Morcos M., Wendt T., Chavakis T., Arnold B., Stern D.M., Nawroth P.P. Understanding RAGE, the receptor for advanced glycation end products. J. Mol. Med. 2005, 83:876-886.
-
(2005)
J. Mol. Med.
, vol.83
, pp. 876-886
-
-
Bierhaus, A.1
Humpert, P.M.2
Morcos, M.3
Wendt, T.4
Chavakis, T.5
Arnold, B.6
Stern, D.M.7
Nawroth, P.P.8
-
4
-
-
18544375186
-
RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease
-
Bucciarelli L.G., Wendt T., Rong L., Lalla E., Hofmann M.A., Goova M.T., Taguchi A., Yan S.F., Yan S.D., Stern D.M., Schmidt A.M. RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease. Cell Mol. Life Sci. 2002, 59:1117-1128.
-
(2002)
Cell Mol. Life Sci.
, vol.59
, pp. 1117-1128
-
-
Bucciarelli, L.G.1
Wendt, T.2
Rong, L.3
Lalla, E.4
Hofmann, M.A.5
Goova, M.T.6
Taguchi, A.7
Yan, S.F.8
Yan, S.D.9
Stern, D.M.10
Schmidt, A.M.11
-
5
-
-
40949163370
-
Histopathological standards for the diagnosis of gastrointestinal inflammation in endoscopic biopsy samples from the dog and cat: a report from the World Small Animal Veterinary Association Gastrointestinal Standardization Group
-
World Small Animal Veterinary Association Gastrointestinal Standardization Group
-
Day M.J., Bilzer T., Mansell J., Wilcock B., Hall E.J., Jergens A.E., Minami T., Willard M.D., Washabau R. Histopathological standards for the diagnosis of gastrointestinal inflammation in endoscopic biopsy samples from the dog and cat: a report from the World Small Animal Veterinary Association Gastrointestinal Standardization Group. J. Comp. Pathol. 2008, 138(Suppl. 1):S1-S43. World Small Animal Veterinary Association Gastrointestinal Standardization Group.
-
(2008)
J. Comp. Pathol.
, vol.138
, pp. S1-S43
-
-
Day, M.J.1
Bilzer, T.2
Mansell, J.3
Wilcock, B.4
Hall, E.J.5
Jergens, A.E.6
Minami, T.7
Willard, M.D.8
Washabau, R.9
-
6
-
-
33745601096
-
High levels of soluble receptor for advanced glycation end products may be a marker of extreme longevity in humans
-
Geroldi D., Falcone C., Minoretti P., Emanuele E., Arra M., D'Angelo A. High levels of soluble receptor for advanced glycation end products may be a marker of extreme longevity in humans. J. Am. Geriatr. Soc. 2006, 54:1149-1150.
-
(2006)
J. Am. Geriatr. Soc.
, vol.54
, pp. 1149-1150
-
-
Geroldi, D.1
Falcone, C.2
Minoretti, P.3
Emanuele, E.4
Arra, M.5
D'Angelo, A.6
-
7
-
-
84897077334
-
Association between fecal S100A12 concentration and histologic, endoscopic, and clinical disease severity in dogs with idiopathic inflammatory bowel disease
-
Heilmann R.M., Grellet A., Allenspach K., Lecoindre P., Day M.J., Priestnall S.L., Toresson L., Procoli F., Grützner N., Suchodolski J.S., Steiner J.M. Association between fecal S100A12 concentration and histologic, endoscopic, and clinical disease severity in dogs with idiopathic inflammatory bowel disease. Vet. Immunol. Immunopathol. 2014, 158:156-166.
-
(2014)
Vet. Immunol. Immunopathol.
, vol.158
, pp. 156-166
-
-
Heilmann, R.M.1
Grellet, A.2
Allenspach, K.3
Lecoindre, P.4
Day, M.J.5
Priestnall, S.L.6
Toresson, L.7
Procoli, F.8
Grützner, N.9
Suchodolski, J.S.10
Steiner, J.M.11
-
8
-
-
84908372992
-
Fecal S100A12 concentrations are increased in dogs with inflammatory bowel disease
-
(abstract)
-
Heilmann R.M., Grellet A., Allenspach K., Lecoindre P., Day M.J., Procoli F., Grützner N., Suchodolski J.S., Steiner J.M. Fecal S100A12 concentrations are increased in dogs with inflammatory bowel disease. J. Vet. Intern. Med. 2012, 26:767. (abstract).
-
(2012)
J. Vet. Intern. Med.
, vol.26
, pp. 767
-
-
Heilmann, R.M.1
Grellet, A.2
Allenspach, K.3
Lecoindre, P.4
Day, M.J.5
Procoli, F.6
Grützner, N.7
Suchodolski, J.S.8
Steiner, J.M.9
-
9
-
-
0033603241
-
RAGE mediates a novel proinflammatory axis: the cell surface receptor for S100/calgranulin polypeptides
-
Hofmann M.A., Drury S., Fu C., Qu W., Taguchi A., Lu Y., Avila C., Kambham N., Bierhaus A., Nawroth P., Neurath M.F., Slattery T., Beach D., McClary J., Nagashima M., Morser J., Stern D., Schmidt A.M. RAGE mediates a novel proinflammatory axis: the cell surface receptor for S100/calgranulin polypeptides. Cell 1999, 97:889-901.
-
(1999)
Cell
, vol.97
, pp. 889-901
-
-
Hofmann, M.A.1
Drury, S.2
Fu, C.3
Qu, W.4
Taguchi, A.5
Lu, Y.6
Avila, C.7
Kambham, N.8
Bierhaus, A.9
Nawroth, P.10
Neurath, M.F.11
Slattery, T.12
Beach, D.13
McClary, J.14
Nagashima, M.15
Morser, J.16
Stern, D.17
Schmidt, A.M.18
-
10
-
-
0142089894
-
Blockade of the receptor for advanced glycation end products: a new target for therapeutic intervention in diabetic complications and inflammatory disorders
-
Hudson B.I., Bucciarelli L.G., Wendt T., Sakaguchi T., Lalla E., Qu W., Lu Y., Lee L., Stern D.M., Naka Y., Ramasamy R., Yan S.D., Yan S.F., D'Agati V., Schmidt A.M. Blockade of the receptor for advanced glycation end products: a new target for therapeutic intervention in diabetic complications and inflammatory disorders. Arch. Biochem. Biophys. 2003, 419:80-88.
-
(2003)
Arch. Biochem. Biophys.
, vol.419
, pp. 80-88
-
-
Hudson, B.I.1
Bucciarelli, L.G.2
Wendt, T.3
Sakaguchi, T.4
Lalla, E.5
Qu, W.6
Lu, Y.7
Lee, L.8
Stern, D.M.9
Naka, Y.10
Ramasamy, R.11
Yan, S.D.12
Yan, S.F.13
D'Agati, V.14
Schmidt, A.M.15
-
11
-
-
0037805712
-
A scoring index for disease activity in canine inflammatory bowel disease
-
Jergens A.E., Schreiner C.A., Frank D.E., Niyo Y., Ahrens F.E., Eckersall P.D., Benson T.J., Evans R. A scoring index for disease activity in canine inflammatory bowel disease. J. Vet. Intern. Med. 2003, 17:291-297.
-
(2003)
J. Vet. Intern. Med.
, vol.17
, pp. 291-297
-
-
Jergens, A.E.1
Schreiner, C.A.2
Frank, D.E.3
Niyo, Y.4
Ahrens, F.E.5
Eckersall, P.D.6
Benson, T.J.7
Evans, R.8
-
12
-
-
84860857259
-
Inflammatory bowel disease in veterinary medicine
-
Jergens A.E., Simpson K.W. Inflammatory bowel disease in veterinary medicine. Front. Biosci. 2012, 4:1404-1419.
-
(2012)
Front. Biosci.
, vol.4
, pp. 1404-1419
-
-
Jergens, A.E.1
Simpson, K.W.2
-
13
-
-
33644808985
-
Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis
-
Koyama H., Shoji T., Yokoyama H., Motoyama K., Mori K., Fukumoto S., Emoto M., Shoji T., Tamei H., Matsuki H., Sakurai S., Yamamoto Y., Yonekura H., Watanabe T., Yamamoto H., Nishizawa Y. Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2005, 25:2587-2593.
-
(2005)
Arterioscler. Thromb. Vasc. Biol.
, vol.25
, pp. 2587-2593
-
-
Koyama, H.1
Shoji, T.2
Yokoyama, H.3
Motoyama, K.4
Mori, K.5
Fukumoto, S.6
Emoto, M.7
Shoji, T.8
Tamei, H.9
Matsuki, H.10
Sakurai, S.11
Yamamoto, Y.12
Yonekura, H.13
Watanabe, T.14
Yamamoto, H.15
Nishizawa, Y.16
-
14
-
-
35148869758
-
Serum and mucosal S100 proteins, calprotectin (S100A8/A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease
-
Leach S.T., Yang Z., Messina I., Song C., Geczy C.L., Cunningham A.M., Day A.S. Serum and mucosal S100 proteins, calprotectin (S100A8/A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease. Scand. J. Gastroenterol. 2007, 42:1321-1331.
-
(2007)
Scand. J. Gastroenterol.
, vol.42
, pp. 1321-1331
-
-
Leach, S.T.1
Yang, Z.2
Messina, I.3
Song, C.4
Geczy, C.L.5
Cunningham, A.M.6
Day, A.S.7
-
15
-
-
0030910830
-
Characterization and functional analysis of the promotor of RAGE, the receptor for advanced glycation end products
-
Li J.H., Schmidt A.M. Characterization and functional analysis of the promotor of RAGE, the receptor for advanced glycation end products. J. Biol. Chem. 1997, 272:16498-16506.
-
(1997)
J. Biol. Chem.
, vol.272
, pp. 16498-16506
-
-
Li, J.H.1
Schmidt, A.M.2
-
16
-
-
84898678975
-
Soluble form of receptor for advanced glycation end-products (sRAGE): do sRAGE ligands or anti-sRAGE autoantibodies interfere with sRAGE quantification?
-
Lorenzi R., Grossin N., Lambert M., Daroux M., Adjoutah Z., Flahaut C., Jacolot P., Tessier F.J., Lefranc D., Desremaux P., Dubucquoi S., Boulanger E. Soluble form of receptor for advanced glycation end-products (sRAGE): do sRAGE ligands or anti-sRAGE autoantibodies interfere with sRAGE quantification?. Ann. Clin. Biochem. 2014, 51:248-257.
-
(2014)
Ann. Clin. Biochem.
, vol.51
, pp. 248-257
-
-
Lorenzi, R.1
Grossin, N.2
Lambert, M.3
Daroux, M.4
Adjoutah, Z.5
Flahaut, C.6
Jacolot, P.7
Tessier, F.J.8
Lefranc, D.9
Desremaux, P.10
Dubucquoi, S.11
Boulanger, E.12
-
17
-
-
77953860277
-
Anti-inflammatory effect of biological treatment in patients with inflammatory bowel diseases: calprotectin and IL-6 changes do not correspond to sRAGE changes
-
Malickova K., Kalousova M., Fucikova T., Bortlik M., Duricova D., Komarek V., Zima T., Janatkova I., Lukas M. Anti-inflammatory effect of biological treatment in patients with inflammatory bowel diseases: calprotectin and IL-6 changes do not correspond to sRAGE changes. Scand. J. Clin. Lab. Invest. 2010, 70:294-299.
-
(2010)
Scand. J. Clin. Lab. Invest.
, vol.70
, pp. 294-299
-
-
Malickova, K.1
Kalousova, M.2
Fucikova, T.3
Bortlik, M.4
Duricova, D.5
Komarek, V.6
Zima, T.7
Janatkova, I.8
Lukas, M.9
-
18
-
-
84899939383
-
Total soluble and endogenous secretory receptor for advanced glycation end products (RAGE) in IBD
-
Meijer B., Hoskin T., Ashcroft A., Burgess L., Keenan J.I., Falvey J., Gearry R.B., Day A.S. Total soluble and endogenous secretory receptor for advanced glycation end products (RAGE) in IBD. J. Crohns Colitis 2014, 8:513-520.
-
(2014)
J. Crohns Colitis
, vol.8
, pp. 513-520
-
-
Meijer, B.1
Hoskin, T.2
Ashcroft, A.3
Burgess, L.4
Keenan, J.I.5
Falvey, J.6
Gearry, R.B.7
Day, A.S.8
-
19
-
-
33644658831
-
Cloning and characterization of the canine receptor for advanced glycation end products
-
Murua Escobar H., Soller J.T., Sterenczak K.A., Sperveslage J.D., Schlueter C., Burchardt B., Eberle N., Fork M., Nimzyk R., Winkler S., Nolte I., Bullerdiek J. Cloning and characterization of the canine receptor for advanced glycation end products. Gene 2006, 369:45-52.
-
(2006)
Gene
, vol.369
, pp. 45-52
-
-
Murua Escobar, H.1
Soller, J.T.2
Sterenczak, K.A.3
Sperveslage, J.D.4
Schlueter, C.5
Burchardt, B.6
Eberle, N.7
Fork, M.8
Nimzyk, R.9
Winkler, S.10
Nolte, I.11
Bullerdiek, J.12
-
20
-
-
80052324298
-
Soluble receptor for advanced glycation endproducts is decreased in patients with juvenile idiopathic arthritis (ERA category) and inversely correlates with disease activity and S100A12 levels
-
Myles A., Viswanath V., Singh Y.P., Aggarwal A. Soluble receptor for advanced glycation endproducts is decreased in patients with juvenile idiopathic arthritis (ERA category) and inversely correlates with disease activity and S100A12 levels. J. Rheumatol. 2011, 38:1994-1999.
-
(2011)
J. Rheumatol.
, vol.38
, pp. 1994-1999
-
-
Myles, A.1
Viswanath, V.2
Singh, Y.P.3
Aggarwal, A.4
-
21
-
-
84908361271
-
Serologic and fecal markers in prediction of acute disease course in canine chronic enteropathies
-
(abstract)
-
Otoni C.C., Heilmann R.M., Garcia-Sancho M., Suchodolski J.S., Steiner J.M., Jergens A.E. Serologic and fecal markers in prediction of acute disease course in canine chronic enteropathies. J. Vet. Intern. Med. 2012, 26:768. (abstract).
-
(2012)
J. Vet. Intern. Med.
, vol.26
, pp. 768
-
-
Otoni, C.C.1
Heilmann, R.M.2
Garcia-Sancho, M.3
Suchodolski, J.S.4
Steiner, J.M.5
Jergens, A.E.6
-
22
-
-
0034695098
-
The biology of the receptor for advanced glycation end products and its ligands
-
Schmidt A.M., Yan S.D., Yan S.F., Stern D.M. The biology of the receptor for advanced glycation end products and its ligands. Biochim. Biophys. Acta 2000, 1498:99-111.
-
(2000)
Biochim. Biophys. Acta
, vol.1498
, pp. 99-111
-
-
Schmidt, A.M.1
Yan, S.D.2
Yan, S.F.3
Stern, D.M.4
-
23
-
-
60649085755
-
Cloning, characterisation, and comparative quantitative expression analyses of receptor for advanced glycation end products (RAGE) transcript forms
-
Sterenczak K.A., Willenbrock S., Barann M., Klemke M., Soller J.T., Eberle N., Nolte I., Bullerdiek J., Murua Escobar H. Cloning, characterisation, and comparative quantitative expression analyses of receptor for advanced glycation end products (RAGE) transcript forms. Gene 2009, 434:35-42.
-
(2009)
Gene
, vol.434
, pp. 35-42
-
-
Sterenczak, K.A.1
Willenbrock, S.2
Barann, M.3
Klemke, M.4
Soller, J.T.5
Eberle, N.6
Nolte, I.7
Bullerdiek, J.8
Murua Escobar, H.9
-
24
-
-
79958099240
-
Quantitative PCR and immunohistochemical analyses of HMGB1 and RAGE expression in canine disseminated histiocytic sarcoma (malignant histiocytosis)
-
Sterenczak K.A., Kleinschmidt S., Wefstaedt P., Eberle N., Hewicker-Trautwein M., Bullerdiek J., Nolte I., Murua Escobar H. Quantitative PCR and immunohistochemical analyses of HMGB1 and RAGE expression in canine disseminated histiocytic sarcoma (malignant histiocytosis). Anticancer Res. 2011, 31:1541-1548.
-
(2011)
Anticancer Res.
, vol.31
, pp. 1541-1548
-
-
Sterenczak, K.A.1
Kleinschmidt, S.2
Wefstaedt, P.3
Eberle, N.4
Hewicker-Trautwein, M.5
Bullerdiek, J.6
Nolte, I.7
Murua Escobar, H.8
-
25
-
-
43449123320
-
Decreased levels of soluble receptor for advanced glycation end products in patients with primary Sjögren's syndrome
-
Stewart C., Cha S., Caudle R.M., Berg K., Katz J. Decreased levels of soluble receptor for advanced glycation end products in patients with primary Sjögren's syndrome. Rheumatol. Int. 2008, 28:771-776.
-
(2008)
Rheumatol. Int.
, vol.28
, pp. 771-776
-
-
Stewart, C.1
Cha, S.2
Caudle, R.M.3
Berg, K.4
Katz, J.5
-
26
-
-
84860324666
-
Soluble RAGE is deficient in neutrophilic asthma and COPD
-
Sukkar M.B., Wood L.G., Tooze M., Simpson J.L., McDonald V.M., Gibson P.G., Wark P.A. Soluble RAGE is deficient in neutrophilic asthma and COPD. Eur. Respir. J. 2012, 39:721-729.
-
(2012)
Eur. Respir. J.
, vol.39
, pp. 721-729
-
-
Sukkar, M.B.1
Wood, L.G.2
Tooze, M.3
Simpson, J.L.4
McDonald, V.M.5
Gibson, P.G.6
Wark, P.A.7
-
27
-
-
73349136806
-
Endoscopic, biopsy, and histopathologic guidelines for the evaluation of gastrointestinal inflammation in companion animals
-
Washabau R.J., Day M.J., Willard M.D., Hall E.J., Jergens A.E., Mansell J., Minami T., Bilzer T.W. Endoscopic, biopsy, and histopathologic guidelines for the evaluation of gastrointestinal inflammation in companion animals. J. Vet. Intern. Med. 2010, 24:10-26.
-
(2010)
J. Vet. Intern. Med.
, vol.24
, pp. 10-26
-
-
Washabau, R.J.1
Day, M.J.2
Willard, M.D.3
Hall, E.J.4
Jergens, A.E.5
Mansell, J.6
Minami, T.7
Bilzer, T.W.8
-
28
-
-
37149020133
-
Acute Kawasaki disease is associated with reverse regulation of soluble receptor for advance glycation end products and its proinflammatory ligand S100A12
-
Wittkowski H., Hirono K., Ichida F., Vogl T., Ye F., Yanlin X., Saito K., Uese K., Miyawaki T., Viemann D., Roth J., Foell D. Acute Kawasaki disease is associated with reverse regulation of soluble receptor for advance glycation end products and its proinflammatory ligand S100A12. Arthritis Rheum. 2007, 56:4174-4181.
-
(2007)
Arthritis Rheum.
, vol.56
, pp. 4174-4181
-
-
Wittkowski, H.1
Hirono, K.2
Ichida, F.3
Vogl, T.4
Ye, F.5
Yanlin, X.6
Saito, K.7
Uese, K.8
Miyawaki, T.9
Viemann, D.10
Roth, J.11
Foell, D.12
|